Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Juli 2026 05:25 ET | Quelle: Research and Markets

Cell-Based Assay Services for Preclinical Use Only Global Market Report 2026 Released — Profiles Charles River, Labcorp, Eurofins and Evotec

Dublin, July 15, 2026 (GLOBE NEWSWIRE) -- The "Cell-Based Assay Services for Preclinical Use Only Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's...
15. Juli 2026 04:06 ET | Quelle: Research and Markets

MEMS for Mobile Devices Market to Reach USD 15.61 Billion by 2031 as 5G, Wearables and Foldable Displays Accelerate Demand

Dublin, July 15, 2026 (GLOBE NEWSWIRE) -- The "MEMS For Mobile Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ...
14. Juli 2026 08:00 ET | Quelle: VisionWave Holdings, Inc.

VisionWave Files U.S. Provisional Patent Application for SkyWeave™, an AI-Orchestrated Satellite-Free Global Communication Ecosystem

SAN DIEGO, July 14, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (NASDAQ: VWAV) (the “Company” or “VisionWave”) today announced the filing of a U.S. provisional patent application...
14. Juli 2026 07:02 ET | Quelle: Axiom Biosciences

Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

Investigational WJ-MSC therapy associated with no deaths at 12 months and statistically significant improvements in long-term cognitive and motor outcomes Results support planned expansion of the...
13. Juli 2026 20:35 ET | Quelle: Mesoblast Limited

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved...
13. Juli 2026 07:32 ET | Quelle: Research and Markets

Veterinary Lab Automation Global Market Report 2023 Now Available, Covers Asia-Pacific, North America, Europe, and More

Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Veterinary Lab Automation Market Report 2026" has been added to ResearchAndMarkets.com's offering. The veterinary lab automation market is...
13. Juli 2026 07:28 ET | Quelle: Research and Markets

Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players

Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Nerve Repair Biomaterials Market Report 2026" has been added to ResearchAndMarkets.com's offering. The nerve repair biomaterials market is...
13. Juli 2026 07:05 ET | Quelle: Longeveron

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease

Longeveron reports new data analysis for its stem cell therapy laromestrocel in mild Alzheimer's disease at AAIC 2026.
13. Juli 2026 06:33 ET | Quelle: SNS Insider pvt ltd

Single-Cell Sequencing Market Size to Reach USD 9.83 Billion by 2035 | SNS Insider

Austin, United States, July 13, 2026 (GLOBE NEWSWIRE) -- The Single-Cell Sequencing Market Size was valued at USD 2.43 Billion in 2025 and is projected to reach USD 9.83 Billion by 2035, expanding...
10. Juli 2026 11:49 ET | Quelle: AB Science

AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM, SUSPENDING SOME NON-PRIORITY CLINICAL TRIALS TO FOCUS ON TWO CLINICAL PROGRAMS Paris, July 10, 2026, 6pm CET AB Science SA...

Vorherige Seite

Nächste Seite